Is PT-141 (Bremelanotide) Legal in California? How to Access It Legally
HealthRX.com
Vyleesi is the FDA-approved, prescription-only form
Key numbers
- 1.75 mgVyleesi dose per prefilled autoinjector injection; prescription-only FDA-approved productSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 45 minutesMinimum wait before sexual activity when injecting Vyleesi as needed; max one dose in 24 hoursSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 40.0%Phase 3 trial share with nausea on Vyleesi, versus 1.3% on placeboSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
See the public record for Bremelanotide
At a glance
- FDA status / Approved as Vyleesi (NDA 210557) on June 21, 2019; 1.75 mg subcutaneous autoinjector; prescription only [1][2]
- Approved use / Premenopausal women with acquired, generalized HSDD [1]
- Not approved for / Men, postmenopausal women, or enhancing sexual performance [1]
- Compounded or research PT-141 / Not Vyleesi and not an FDA-approved drug [1][3]
- FDA bulk-substance lists / Bremelanotide is not listed on FDA's bulk-substance lists or the HHS October 2026 draft peptide enforcement-discretion list [4][5][6]
- Boxed warning / None [1]
- Main label contraindication / Uncontrolled hypertension or known cardiovascular disease [1]
- Access route / A prescription for Vyleesi [1][2]
What is the federal legal status?
Bremelanotide is FDA-approved as Vyleesi under NDA 210557; the original approval date was June 21, 2019 [2]. It is a 1.75 mg subcutaneous injection in a prefilled autoinjector and is prescription only [1][2]. The FDA-approved use is premenopausal women with acquired, generalized HSDD: low sexual desire causing marked distress or interpersonal difficulty that is not due to a medical or psychiatric condition, relationship problems, or a medication or drug [1]. The label says it is not indicated for postmenopausal women or men, and not to enhance sexual performance [1]. Vyleesi has no boxed warning [1].
What about compounded or research PT-141?
Vyleesi is the FDA-approved bremelanotide product. Products sold as PT-141, compounded bremelanotide or research-use peptide are not Vyleesi and are not FDA-approved drugs; compounded drugs are not reviewed by FDA for safety, effectiveness or quality before marketing [1][3]. Bremelanotide does not appear on FDA's page of bulk substances that may raise significant safety risks, or in any category on FDA's bulk-substance lists, and it is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [4][5][6].
Does California law change this?
Federal approval and prescription-only status apply in every state [1][2]. California's own rules on prescribing, telehealth and compounding are not described here, so no California-specific legal claim is made about any particular telehealth prescription or compounded product.
What people on Reddit report
These are Reddit posts about getting compounded tirzepatide shipped to California. They describe how state rules and telehealth shipping have affected access to that compounded drug.
California has particularly strict rules around compounding so you have fewer options as a consequence.Read the source discussion
Tbh I prefer California's stricter regulations. I'm injecting something into my body and essentially doing a hail Mary it's not poison because I don't have a lab to test what it isRead the source discussion
How is Vyleesi used?
Vyleesi is prescription only [1][2]. The label says to inject 1.75 mg subcutaneously into the abdomen or thigh, as needed, at least 45 minutes before anticipated sexual activity; no more than one dose in 24 hours; more than 8 doses per month is not recommended; and to stop after 8 weeks if there is no improvement [1]. The duration of effect after a dose is unknown [1].
What does the label say to watch for?
Vyleesi is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease [1]. The label says it is not recommended for patients at high risk for cardiovascular disease and says to assess cardiovascular risk and ensure blood pressure is well controlled before starting and periodically during treatment [1]. In the phase 3 trials, nausea occurred in 40.0% on Vyleesi vs 1.3% on placebo; flushing 20.3% vs 0.3%; injection site reactions 13.2% vs 8.4%; headache 11.3% vs 1.9%; and vomiting 4.8% vs 0.2% [1]. Focal hyperpigmentation was reported by 1% of patients who received up to 8 doses per month vs none on placebo, with higher risk in darker skin and with daily dosing [1].
What is the practical answer?
Access to bremelanotide means a prescription for Vyleesi, the only FDA-approved bremelanotide product, for its labeled HSDD population [1][2]. Compounded and research PT-141 are not FDA-approved drugs [1][3].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Questions worth asking
Frequently asked questions
Is PT-141 legal in California?
Can I get PT-141 by telehealth in California?
Is compounded PT-141 legal?
What is Vyleesi approved for?
What are the main label warnings?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Where can I buy PT-141 peptide for men?
Vyleesi is the only FDA-approved bremelanotide product, and it is prescription only. Its label does not indicate it for men. Products sold as PT-141, compounded bremelanotide or research-use peptides are not Vyleesi and are not FDA-approved drugs.
What does PT-141 make you feel like?
The reported effects are nausea, flushing, injection site reactions, headache and vomiting. Nausea occurred in 40.0% on Vyleesi vs 1.3% on placebo, and flushing in 20.3% vs 0.3%. The reported side effects are the only description of how it affects people.
References
Show all 7 referencesHide references
- U.S. National Library of Medicine, DailyMed. Vyleesi (bremelanotide) injection, 1.75 mg subcutaneous autoinjector prescribing information. Vyleesi (bremelanotide) injection, 1.75 mg subcutaneous autoinjector label
- U.S. Food and Drug Administration.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- Official web page.
- Reddit participants. Why is it so hard to get compounded Zepbound (7.5mg) in CA? (+ venting about insurance/Wegovy HD side effects) (r/tirzepatidecompound). Accessed 2026-11-11.